Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
jesus sobrido
(1 results)?
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651.
N Engl J Med. 2022.
PMID: 35139274
Clinical Trial.
Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O, Pérez J, Soberino J, Racca F, Cortés J, Villanueva J.
Méndez O, et al. Among authors: soberino j.
Int J Mol Sci. 2019 Nov 26;20(23):5950. doi: 10.3390/ijms20235950.
Int J Mol Sci. 2019.
PMID: 31779212
Free PMC article.
Review.
Item in Clipboard
Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Pérez-García J, Soberino J, Racca F, Gion M, Stradella A, Cortés J.
Pérez-García J, et al. Among authors: soberino j.
Expert Opin Biol Ther. 2020 Sep;20(9):981-989. doi: 10.1080/14712598.2020.1769063. Epub 2020 May 25.
Expert Opin Biol Ther. 2020.
PMID: 32450725
Review.
Item in Clipboard
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
Chic N, Schettini F, Brasó-Maristany F, Sanfeliu E, Adamo B, Vidal M, Martínez D, Galván P, González-Farré B, Cortés J, Gavilá J, Saura C, Oliveira M, Pernas S, Martínez-Sáez O, Soberino J, Ciruelos E, Carey LA, Muñoz M, Perou CM, Pascual T, Bellet M, Prat A.
Chic N, et al. Among authors: soberino j.
EBioMedicine. 2021 Jul;69:103451. doi: 10.1016/j.ebiom.2021.103451. Epub 2021 Jun 20.
EBioMedicine. 2021.
PMID: 34161883
Free PMC article.
Clinical Trial.
Item in Clipboard
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial.
Pérez-García JM, Llombart-Cussac A, G Cortés M, Curigliano G, López-Miranda E, Alonso JL, Bermejo B, Calvo L, Carañana V, de la Cruz Sánchez S, M Vázquez R, Prat A, R Borrego M, Sampayo-Cordero M, Seguí-Palmer MÁ, Soberino J, Malfettone A, Schmid P, Cortés J.
Pérez-García JM, et al. Among authors: soberino j.
Eur J Cancer. 2021 May;148:382-394. doi: 10.1016/j.ejca.2021.02.028. Epub 2021 Mar 29.
Eur J Cancer. 2021.
PMID: 33794440
Clinical Trial.
Item in Clipboard
Cite
Cite